Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Hypha Labs (FUNI) Return on Sales (2016 - 2025)

Hypha Labs (FUNI) has disclosed Return on Sales for 15 consecutive years, with 15.9% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Sales rose 1880.0% year-over-year to 15.9%, compared with a TTM value of 29.22% through Sep 2025, up 3212.0%, and an annual FY2025 reading of 29.22%, up 3212.0% over the prior year.
  • Return on Sales was 15.9% for Q3 2025 at Hypha Labs, down from 19.81% in the prior quarter.
  • Across five years, Return on Sales topped out at 66.97% in Q4 2024 and bottomed at 4.95% in Q3 2023.
  • Average Return on Sales over 5 years is 5.54%, with a median of 0.4% recorded in 2021.
  • The sharpest move saw Return on Sales plummeted -517bps in 2023, then soared 7044bps in 2024.
  • Year by year, Return on Sales stood at 0.4% in 2021, then surged by 107bps to 0.03% in 2022, then plummeted by -13266bps to 3.47% in 2023, then soared by 2030bps to 66.97% in 2024, then tumbled by -76bps to 15.9% in 2025.
  • Business Quant data shows Return on Sales for FUNI at 15.9% in Q3 2025, 19.81% in Q2 2025, and 28.32% in Q1 2025.